Role of the Mespere Venus 1000 in Predicting Heart Failure Hospital Readmissions

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

May 31, 2016

Conditions
ADHF
Interventions
DEVICE

Mespere Venus 1000 CVP System

An adhesive patch (connected to the Mespere Venus 1000 System) is placed on the neck of the subject. A CVP measurement is recorded at time of patient's hospital admission and discharge. CVP readings will remain concealed from the treating team.

Trial Locations (1)

M5B 1W8

St. Michael's Hospital, Toronto

Sponsors
All Listed Sponsors
lead

Mespere Lifesciences Inc.

INDUSTRY